SavedAdd your journal

Journals / Akademik Gastroenteroloji Dergisi / 2011 / Cilt: 10 - Sayı: 3

Lichenoid eruption occurring during chronic hepatitis C treatment with interferon-alpha 2-b plus ribavirin

İnterferon alfa 2-b ve ribavirin ile tedavi edilen kronik hepatit C’li hastada geliflen likenoid döküntüler

Hakan ÜNAL
Derya UÇMAK
Murat KORKMAZ
Feyzullah UÇMAK
Haldun SELÇUK
Uğur YILMAZ
Pages
116–118
Publication Date
2011-12-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our patient had hepatitis C virus infection and developed lichenoid eruptions during the 9th month of interferon plus ribavirin treatment

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Approximately half of the chronic hepatitis C virus infection patients might develop at least one extrahepatic manifestation during the course of the disease.
📊
Key Findings & Data:Lichen planus is in group B in accordance with its relation with hepatitis C virus infection, meaning that the prevalence of this disorder is higher than in controls.
💡
Conclusion & Impact:Our patient had hepatitis C virus infection and developed lichenoid eruptions during the 9th month of interferon plus ribavirin treatment
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Hepatit C · lichen planus · ekstrahepatik bulgular

Abstract

Approximately half of the chronic hepatitis C virus infection patients might develop at least one extrahepatic manifestation during the course of the disease. Lichen planus is in group B in accordance with its relation with hepatitis C virus infection, meaning that the prevalence of this disorder is higher than in controls. On the other hand, lichenoid eruptions may arise as an adverse reaction of interferon therapy in chronic hepatitis C virus infection. Our patient had hepatitis C virus infection and developed lichenoid eruptions during the 9th month of interferon plus ribavirin treatment

Özet

Kronik hepatit C'li hastaların yaklaşık yarısında hastalık seyri esnasında en az bir karaciğer dışı bulgu ortaya çıkar. Liken planusun hepatit C ile ilişkisi grup B olarak tanımlanır ki bunun anlamı kontrollere göre daha yüksek sıklıkda görülmekte olduğudur. Bunun yanında likenoid döküntüler kronik hepatit C tedavisine bağlı gelişen bir yan etki olarak da karşımıza çıkabilir. Bizim vakamız interferon 2-b+ribavirin tedavisinin 9. ayında likenoid döküntüleri ortaya çıkan bir hastadır.

🔖

Cite This Article

ÜNAL, H., UÇMAK, D., KORKMAZ, M., UÇMAK, F., SELÇUK, H., YILMAZ, U. (2011). Lichenoid eruption occurring during chronic hepatitis C treatment with interferon-alpha 2-b plus ribavirin. Akademik Gastroenteroloji Dergisi, Cilt: 10 - Sayı: 3, 116–118. https://ajindex.com/articles/712132

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Hadziyannis SJ. The spectrum of extrahepatic manifestations in hepatitis C virus infection. J Viral Hepat 1997;4:9-28. Sène D, Saadoun D, Limal N, et al. Update in hepatitis C virus associated extrahepatic manifestations. Rev Med Interne 2007;28: 388-93.
  2. Cacoub P, Renou C, Rosenthal E, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) 2000;79:47-56.
  3. Nagao Y, Sata M. Hepatitis C virus and lichen planus. J Gastroenterol Hepatol 2004;19:1101-13. Thornhill MH. Immune mechanisms in oral lichen planus. Acta Odontol Scand 2001;59:174-7.
  4. Kirtak N, Inalöz HS, Ozgöztasi, Erba¤ci Z. The prevalence of hepatitis C virus infection in patients with lichen planus in Gaziantep region of Turkey. Eur J Epidemiol 2000;16:1159-61.
  5. Nagao Y, Sata M, Abe K, et al. Immunological evaluation in oral lichen planus with chronic hepatitis C. J Gastroenterol 1997;32:324-9.
  6. Femiano F, Scully C. Functions of the cytokines in relation oral lichen planus-hepatitis C. Med Oral Patol Oral Cir Bucal 2005;10 (Suppl 1):E40-4. Doutre MS, Beylot C, Couzigou P, et al. Lichen planus and virus C hepatitis: disappearance of the lichen under interferon alfa therapy. Dermatology 1992;184:229. Boccia S, Gamberini S, Dalla Libera M, et al. Lichen planus and interferon therapy for hepatitis C. Gastroenterology 1993;105:1921-2.
  7. Barreca T, Corsini G, Franceschini R, et al. Lichen planus induced by interferon-alpha-2a therapy for chronic active hepatitis C. Eur J Gastroenterol Hepatol 1995;7:367-8.
  8. Nagao Y, Sata M, Ide T, et al. Development and exacerbation of oral lichen planus during and after interferon therapy for hepatitis C. Eur J Clin Invest 1996;26:1171-4.
  9. Schlesinger TE, Camisa C, Gay JD, et al. Oral erosive lichen planus with epidermolytic hyperkeratosis during interferon alfa-2b therapy for chronic hepatitis C virus infection. J Am Acad Dermatol 1997;36:1023-5.
  10. Dalekos GN, Christodoulou D, Kistis KG, et al. A prospective evaluation of dermatological side-effects during alpha-interferon therapy for chronic viral hepatitis. Eur J Gastroenterol Hepatol 1998; 10:933-9.
  11. Protzer U, Ochsendorf FR, Leopolder-Ochsendorf A, Holtermüller KH. Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C. Gastroenterology 1993;104:903-5.
  12. Harden D, Skelton H, Smit